Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vivus Rallies on Positive Results for Obesity Drug
Seeking Alpha
Wednesday, September 22, 2010 - 10:06am
tags:
Vivus, obesity, Qnexa
Mylan Gets Order Blocking Glaxo Sale of Generic Paxil
Bloomberg
Wednesday, September 22, 2010 - 9:59am
tags:
Mylan, GSK, generics, Paxil, antidepressants
Takeda Seeks 10-Fold Jump in China Sales by 2015, Hasegawa Says
Bloomberg
Wednesday, September 22, 2010 - 9:58am
tags:
Takeda, China
Novartis Cushing's Drug Passes Late-Stage Test
TheStreet.com
Wednesday, September 22, 2010 - 9:58am
tags:
Novartis, Cushing's disease
Glaxo, Theravance report Relovair safety data
Yahoo/AP
Wednesday, September 22, 2010 - 9:57am
tags:
GSK, Theravance, asthma, lung disease, Relovair
Novartis gains FDA approval for Gilenya drug
Marketwatch
Wednesday, September 22, 2010 - 9:53am
tags:
FDA, Gilenia, Novartis, Gilenya, MS, multiple sclerosis
3,000 Abbott Workers Losing Their Jobs May Have Patent Lawyers to Blame
BNET Pharma
Tuesday, September 21, 2010 - 7:53pm
tags:
Abbott Laboratories, Solvay, layoffs, patents
A New Way To Find Cancer Drugs
Forbes
Tuesday, September 21, 2010 - 7:51pm
tags:
cancer, Sanofi, targeted therapeutics
U.S. Seeks to Join Pfizer Whistleblower Lawsuit Over Marketing of Rapamune
Bloomberg
Tuesday, September 21, 2010 - 7:49pm
tags:
whistleblowers, Pfizer, Rapamune, off-label
Dendreon signs Provenge supply deal with Glaxo
Bizjournals.com
Tuesday, September 21, 2010 - 1:17pm
tags:
Dendreon, Provenge, GSK, prostate cancer, vaccines
Vivus: Weight Loss Extends Two Years
TheStreet.com
Tuesday, September 21, 2010 - 12:07pm
tags:
obesity, Vivus, Qnexa
Watch for Continued Gains in Shares of Medicis Pharmaceutical
Comtex Smartrend
Tuesday, September 21, 2010 - 12:06pm
tags:
Medicis
Chelsea Therapeutics Shares Fly on Hypotension Drug Trials Promise
Seeking Alpha
Tuesday, September 21, 2010 - 12:02pm
tags:
hypotension, Chelsea Therapeutics, Northera
Merck KGaA Sees Single-Digit Serono Sales Growth as Erbitux Revenue Rises
Bloomberg
Tuesday, September 21, 2010 - 12:00pm
tags:
Merck KGaA, Merck Serono, Erbitux
Ranbaxy Has Sole Approval to Sell Generic Aricept in U.S., Regulator Says
Bloomberg
Tuesday, September 21, 2010 - 11:59am
tags:
Ranbaxy, Aricept, generics, Eisai, Alzheimer's disease
Santarus: A Stock With Potential to Run
Seeking Alpha
Tuesday, September 21, 2010 - 11:16am
tags:
Santarus, Zegerid, Glumetza
Fewer Docs Use ‘Closed’ Web Sites To Swap Info
Pharmalot
Tuesday, September 21, 2010 - 11:15am
tags:
physicians
Novartis Aims for China Trial of Novel Cancer Drug in 2013
Seeking Alpha
Tuesday, September 21, 2010 - 11:14am
tags:
Novartis, China, cancer
Dapagliflozin: Potential Blockbuster, No Me-Too About It
Motley Fool
Tuesday, September 21, 2010 - 11:13am
tags:
diabetes, Bristol-Myers Squibb, Dapagliflozin, AstraZeneca
Abbott to cut 3,000 jobs following Solvay deal
Yahoo/AP
Tuesday, September 21, 2010 - 11:10am
tags:
layoffs, Abbott Laboratories, Solvay, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.